cafepharma news hand selected daily
get news headlines in your inbox each weekday

insulin

Tagged:

Halozyme Study Results Demonstrate Significantly Less Absorption Variability for Insulin Lispro Administered with PH20 Enzyme

BusinessWire

Login or register to post comments

Tagged:

Sanofi Expands in Diabetes With Rights to Novel Drug

Bloomberg

Login or register to post comments

Tagged:

Insulin drugs could lose $6.1B to biosimilars

Fierce Pharma

Login or register to post comments

Tagged:

Doctors Prescribe Caution With Sanofi Insulin’s Ties to Cancer

Bloomberg

Login or register to post comments

Tagged:

Cancer Alert Probed as Sanofi, Novo Diabetes Drugs Put to Test

Bloomberg

Login or register to post comments

Tagged:

Sanofi-Aventis to launch insulin research program

Marketwatch

Login or register to post comments

Tagged:

Sanofi Says Lantus Studies ‘Inconsistent’ and ‘Inconclusive’

Bloomberg

Login or register to post comments

Tagged:

Halozyme Begins Phase 2 Clinical Trial of Insulin-PH20 in Type 2 Diabetic Patients

Yahoo

Login or register to post comments

Tagged:

FDA to review safety of Sanofi's Lantus

Marketwatch

Login or register to post comments

Tagged:

Sanofi Stock Drop Spurred Journal’s Rush to Publish Lantus Data

Bloomberg

Login or register to post comments

New on Cafepharma

Funny or interesting conversations reps hear in the field
Overheard in the Field
Keep up with the latest at cafepharma:
follow us on twitter
GE Healthcare IT
HIV Reps
New message boards
Baxter IT
Pacific Pulmonary Services
Pacific Pulmonary Services IT
New message board category
Pharma IT Boards

<a href="http://finance.yahoo.com">Yahoo! Finance</a><br/><a href="http://finance.yahoo.com/q?s=ABT">Quote for ABT</a>